FR2649888B1
(fr)
*
|
1989-07-18 |
1994-08-26 |
Exsymol Sa |
Produits pour applications cutanees, a effets cosmetiques ou/et therapeutiques
|
FR2657258A1
(fr)
|
1990-01-19 |
1991-07-26 |
Farmalyoc |
Nouvelle forme unitaire, solide et poreuse comprenant des particules sous forme de perles ainsi que sa preparation.
|
US5417985A
(en)
*
|
1989-07-20 |
1995-05-23 |
Farmalyoc |
Solid and porous single dosage form comprising particles in the form of beads and its preparation
|
US5188825A
(en)
*
|
1989-12-28 |
1993-02-23 |
Iles Martin C |
Freeze-dried dosage forms and methods for preparing the same
|
FR2661610B1
(fr)
*
|
1990-05-02 |
1994-09-30 |
Rhone Poulenc Sante |
Nouvelle forme lyophilisee de la diosmine et sa preparation.
|
US5458884A
(en)
*
|
1992-09-10 |
1995-10-17 |
Britton; Peter |
Bioerodible device for administering active ingredients
|
US5981719A
(en)
|
1993-03-09 |
1999-11-09 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
US6090925A
(en)
|
1993-03-09 |
2000-07-18 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
US5843347A
(en)
*
|
1993-03-23 |
1998-12-01 |
Laboratoire L. Lafon |
Extrusion and freeze-drying method for preparing particles containing an active ingredient
|
CA2128821A1
(en)
*
|
1993-07-27 |
1995-01-28 |
Dilip J. Gole |
Freeze-dried pharmaceutical dosage form and process for separation thereof
|
US5962477A
(en)
*
|
1994-04-12 |
1999-10-05 |
Adolor Corporation |
Screening methods for cytokine inhibitors
|
US6190691B1
(en)
|
1994-04-12 |
2001-02-20 |
Adolor Corporation |
Methods for treating inflammatory conditions
|
FR2720645B1
(fr)
*
|
1994-06-03 |
1996-08-02 |
Oreal |
Procédé d'obtention d'une matière première sous forme de granulés, matière première sous forme de granulés et son utilisation dans le domaine cosmétique, capillaire, vétérinaire ou pharmaceutique.
|
EP0782850A4
(de)
*
|
1994-10-13 |
1998-03-04 |
Wakamoto Pharma Co Ltd |
Lyophilisierte zubereitung zur herstellung eines reversibel thermogelierenden arzniemittels auf wasserbasis
|
FR2726469B1
(fr)
*
|
1994-11-08 |
1996-12-13 |
Adir |
Composition pharmaceutique pour l'administration orale de flavonoides
|
US5849761A
(en)
*
|
1995-09-12 |
1998-12-15 |
Regents Of The University Of California |
Peripherally active anti-hyperalgesic opiates
|
US6573282B1
(en)
|
1995-09-12 |
2003-06-03 |
Adolor Corporation |
Peripherally active anti-hyperalgesic opiates
|
US20050267302A1
(en)
*
|
1995-12-11 |
2005-12-01 |
G.D. Searle & Co. |
Eplerenone crystalline form exhibiting enhanced dissolution rate
|
US5817343A
(en)
*
|
1996-05-14 |
1998-10-06 |
Alkermes, Inc. |
Method for fabricating polymer-based controlled-release devices
|
US20010018417A1
(en)
|
1996-07-01 |
2001-08-30 |
Carson James W. |
Virginiamycin mixture
|
US6020004A
(en)
*
|
1997-04-17 |
2000-02-01 |
Amgen Inc. |
Biodegradable microparticles for the sustained delivery of therapeutic drugs
|
GB9802088D0
(en)
*
|
1998-01-30 |
1998-03-25 |
Scherer Ltd R P |
Pharmaceutical products
|
US8236352B2
(en)
*
|
1998-10-01 |
2012-08-07 |
Alkermes Pharma Ireland Limited |
Glipizide compositions
|
JP2002525311A
(ja)
*
|
1998-10-01 |
2002-08-13 |
エラン ファーマ インターナショナル,リミティド |
徐放性ナノ粒子組成物
|
US8293277B2
(en)
*
|
1998-10-01 |
2012-10-23 |
Alkermes Pharma Ireland Limited |
Controlled-release nanoparticulate compositions
|
US20040013613A1
(en)
*
|
2001-05-18 |
2004-01-22 |
Jain Rajeev A |
Rapidly disintegrating solid oral dosage form
|
US20090297602A1
(en)
*
|
1998-11-02 |
2009-12-03 |
Devane John G |
Modified Release Loxoprofen Compositions
|
US20070160675A1
(en)
*
|
1998-11-02 |
2007-07-12 |
Elan Corporation, Plc |
Nanoparticulate and controlled release compositions comprising a cephalosporin
|
DE69939748D1
(de)
*
|
1998-11-02 |
2008-11-27 |
Elan Pharma Int Ltd |
Multipartikuläre zusammensetzung von methylphenidat mit modifizierter freisetzung
|
US20040115134A1
(en)
*
|
1999-06-22 |
2004-06-17 |
Elan Pharma International Ltd. |
Novel nifedipine compositions
|
DE19931708A1
(de)
|
1999-07-08 |
2001-01-18 |
Bayer Ag |
Verfahren zur Herstellung schnell zerfallender, fester pharmazeutischer Zubereitungen
|
US20030203884A1
(en)
*
|
1999-11-09 |
2003-10-30 |
Pharmacia Corporation |
Methods for the treatment or prophylaxis of aldosterone-mediated pathogenic effects in a subject using an epoxy-steroidal aldosterone antagonist
|
US20030096798A1
(en)
*
|
1999-11-09 |
2003-05-22 |
Williams Gordon H. |
Methods for the treatment or prophylaxis of aldosterone-mediated pathogenic effects in a subject using an epoxy-steroidal aldosterone antagonist
|
CN100413881C
(zh)
*
|
1999-12-08 |
2008-08-27 |
法马西亚公司 |
依匹乐酮晶形
|
UA74539C2
(en)
|
1999-12-08 |
2006-01-16 |
Pharmacia Corp |
Crystalline polymorphous forms of celecoxib (variants), a method for the preparation thereof (variants), a pharmaceutical composition (variants)
|
CZ20013162A3
(cs)
*
|
1999-12-08 |
2002-06-12 |
Pharmacia Corporation |
Prostředky obsahující inhibitor cyklooxygenasy-2 mající rychlý nástup terapeutického účinku
|
US20030083493A1
(en)
*
|
1999-12-08 |
2003-05-01 |
Barton Kathleen P. |
Eplerenone drug substance having high phase purity
|
DE10008305A1
(de)
*
|
2000-02-23 |
2001-09-06 |
Henkel Kgaa |
Mittel zur Reinigung und Pflege von Haut und/oder Haaren
|
US6316029B1
(en)
|
2000-05-18 |
2001-11-13 |
Flak Pharma International, Ltd. |
Rapidly disintegrating solid oral dosage form
|
AR035642A1
(es)
*
|
2000-05-26 |
2004-06-23 |
Pharmacia Corp |
Uso de una composicion de celecoxib para el alivio rapido del dolor
|
PE20020146A1
(es)
*
|
2000-07-13 |
2002-03-31 |
Upjohn Co |
Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2)
|
AU2001279050B2
(en)
*
|
2000-07-27 |
2006-10-19 |
Pharmacia Corporation |
Epoxy-steroidal aldosterone antagonist and beta-adrenergic antagonist combination therapy for treatment of congestive heart failure
|
US6716829B2
(en)
|
2000-07-27 |
2004-04-06 |
Pharmacia Corporation |
Aldosterone antagonist and cyclooxygenase-2 inhibitor combination therapy to prevent or treat inflammation-related cardiovascular disorders
|
DK1313485T3
(da)
*
|
2000-08-28 |
2005-12-27 |
Pharmacia Corp |
Anvendelse af en aldosteronreceptorantagonist til forbedring af kognitiv funktion
|
AU2002212200A1
(en)
*
|
2000-08-31 |
2002-03-13 |
Universiteit Gent |
Controlled release pharmaceutical pellet compositions for reducing side effects of drugs
|
US7198795B2
(en)
*
|
2000-09-21 |
2007-04-03 |
Elan Pharma International Ltd. |
In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions
|
US20040033267A1
(en)
*
|
2002-03-20 |
2004-02-19 |
Elan Pharma International Ltd. |
Nanoparticulate compositions of angiogenesis inhibitors
|
US20020131990A1
(en)
*
|
2000-11-30 |
2002-09-19 |
Barkalow David G. |
Pullulan free edible film compositions and methods of making the same
|
BR0206654A
(pt)
*
|
2001-01-26 |
2004-02-25 |
Schering Corp |
Combinações de ativador(es) de receptor ativado por proliferação de peroxisoma (ppar) e inibidor(es) de absorção de esterol e tratamentos para indicações vasculares
|
US20060287254A1
(en)
*
|
2001-01-26 |
2006-12-21 |
Schering Corporation |
Use of substituted azetidinone compounds for the treatment of sitosterolemia
|
DK1232746T3
(da)
*
|
2001-02-14 |
2006-10-23 |
Forte Iq B V |
Farmaceutisk sammensætning indeholdende xanthan gummi
|
US6465014B1
(en)
*
|
2001-03-21 |
2002-10-15 |
Isp Investments Inc. |
pH-dependent sustained release, drug-delivery composition
|
EP1405635A1
(de)
*
|
2001-06-07 |
2004-04-07 |
Tanabe Seiyaku Co., Ltd. |
Funktionale körnchen enthaltende präparate, die sich in der mundhöhle schnell auflösen
|
US20030220310A1
(en)
*
|
2001-07-27 |
2003-11-27 |
Schuh Joseph R. |
Epoxy-steroidal aldosterone antagonist and calcium channel blocker combination therapy for treatment of congestive heart failure
|
US7053080B2
(en)
*
|
2001-09-21 |
2006-05-30 |
Schering Corporation |
Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
|
ES2272776T3
(es)
*
|
2001-09-21 |
2007-05-01 |
Schering Corporation |
Tratamiento de xantomas con derivados de azetidinona como inhibidores de la absorcion de esterol.
|
CA2461080A1
(en)
*
|
2001-09-25 |
2003-04-03 |
Pharmacia Corporation |
Solid-state forms of n-(2-hydroxyacetyl)-5-(4-piperidyl)-4-(4-pyrimidinyl)-3-(4-chlorophenyl)pyrazole
|
CA2463495C
(en)
*
|
2001-10-12 |
2011-05-24 |
Elan Pharma International Ltd. |
Compositions having a combination of immediate release and controlled release characteristics
|
EP1471887B1
(de)
*
|
2002-02-04 |
2010-04-21 |
Elan Pharma International Ltd. |
Arzneistoffnanopartikel mit lysozym-oberflächenstabilisator
|
US20040101566A1
(en)
*
|
2002-02-04 |
2004-05-27 |
Elan Pharma International Limited |
Novel benzoyl peroxide compositions
|
GB0205253D0
(en)
|
2002-03-06 |
2002-04-17 |
Univ Gent |
Immediate release pharmaceutical granule compositions and a continuous process for making them
|
AU2003222027A1
(en)
*
|
2002-03-20 |
2003-10-08 |
Elan Pharma International Limited |
Fast dissolving dosage forms having reduced friability
|
US7131997B2
(en)
*
|
2002-03-29 |
2006-11-07 |
Scimed Life Systems, Inc. |
Tissue treatment
|
US7462366B2
(en)
|
2002-03-29 |
2008-12-09 |
Boston Scientific Scimed, Inc. |
Drug delivery particle
|
US7094369B2
(en)
*
|
2002-03-29 |
2006-08-22 |
Scimed Life Systems, Inc. |
Processes for manufacturing polymeric microspheres
|
US7053134B2
(en)
*
|
2002-04-04 |
2006-05-30 |
Scimed Life Systems, Inc. |
Forming a chemically cross-linked particle of a desired shape and diameter
|
CA2492339A1
(en)
|
2002-06-12 |
2003-12-24 |
Boston Scientific Limited |
Bulking agents
|
EP1551457A1
(de)
*
|
2002-07-16 |
2005-07-13 |
Elan Pharma International Limited |
Flüssige dosierzusammensetzungen von stabilen wirkstoffen in nanoteilchenform
|
GB2399084B
(en)
|
2002-07-30 |
2007-01-31 |
Univ Liverpool |
Porous beads and method of production thereof
|
US7842377B2
(en)
*
|
2003-08-08 |
2010-11-30 |
Boston Scientific Scimed, Inc. |
Porous polymeric particle comprising polyvinyl alcohol and having interior to surface porosity-gradient
|
US7449236B2
(en)
*
|
2002-08-09 |
2008-11-11 |
Boston Scientific Scimed, Inc. |
Porous polymeric particle comprising polyvinyl alcohol and having interior to surface porosity-gradient
|
UY27939A1
(es)
|
2002-08-21 |
2004-03-31 |
Glaxo Group Ltd |
Compuestos
|
US8012454B2
(en)
|
2002-08-30 |
2011-09-06 |
Boston Scientific Scimed, Inc. |
Embolization
|
AU2003268380A1
(en)
*
|
2002-10-04 |
2004-05-04 |
Elan Pharma International Limited |
Gamma irradiation of solid nanoparticulate active agents
|
JP2006504799A
(ja)
|
2002-10-16 |
2006-02-09 |
ドクトル ズベラック スキン ウント ヘルス ケア アクチェンゲゼルシャフト |
形成物の身体表面への利用法
|
US7883490B2
(en)
*
|
2002-10-23 |
2011-02-08 |
Boston Scientific Scimed, Inc. |
Mixing and delivery of therapeutic compositions
|
US7588825B2
(en)
*
|
2002-10-23 |
2009-09-15 |
Boston Scientific Scimed, Inc. |
Embolic compositions
|
WO2004043440A1
(en)
*
|
2002-11-12 |
2004-05-27 |
Elan Pharma International Ltd. |
Fast-disintegrating solid dosage forms being not friable and comprising pullulan
|
US20040156894A1
(en)
*
|
2003-02-07 |
2004-08-12 |
Grother Leon Paul |
Use of edible acids in fast-dispersing pharmaceutical solid dosage forms
|
US20100297252A1
(en)
|
2003-03-03 |
2010-11-25 |
Elan Pharma International Ltd. |
Nanoparticulate meloxicam formulations
|
US8512727B2
(en)
*
|
2003-03-03 |
2013-08-20 |
Alkermes Pharma Ireland Limited |
Nanoparticulate meloxicam formulations
|
KR100638104B1
(ko)
*
|
2003-03-05 |
2006-10-25 |
학교법인 포항공과대학교 |
산화철 나노입자 함유 콜로이드 조성물의 제조방법
|
US7459442B2
(en)
*
|
2003-03-07 |
2008-12-02 |
Schering Corporation |
Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
|
CN1756756A
(zh)
*
|
2003-03-07 |
2006-04-05 |
先灵公司 |
取代的2-吖丁啶酮化合物、其制剂及其治疗高胆甾醇血症的用途
|
ES2311806T3
(es)
|
2003-03-07 |
2009-02-16 |
Schering Corporation |
Compuesto de azetidinona sustituidos, fornulaciones y usos de los mismos para el tratamiento de hipercolesterolemia.
|
US7842232B2
(en)
*
|
2003-05-22 |
2010-11-30 |
Elan Pharma International, Ltd. |
Sterilization of dispersions of nanoparticulate active agents with gamma radiation
|
US7976823B2
(en)
*
|
2003-08-29 |
2011-07-12 |
Boston Scientific Scimed, Inc. |
Ferromagnetic particles and methods
|
US7943179B2
(en)
*
|
2003-09-23 |
2011-05-17 |
Massachusetts Institute Of Technology |
pH triggerable polymeric particles
|
US20050123596A1
(en)
*
|
2003-09-23 |
2005-06-09 |
Kohane Daniel S. |
pH-triggered microparticles
|
US7901770B2
(en)
*
|
2003-11-04 |
2011-03-08 |
Boston Scientific Scimed, Inc. |
Embolic compositions
|
DE102004007526A1
(de)
*
|
2004-02-17 |
2005-09-01 |
Oetjen, Georg-Wilhelm, Dr. |
Verfahren und Einrichtung zur Gefriertrocknung von Produkten
|
US7736671B2
(en)
*
|
2004-03-02 |
2010-06-15 |
Boston Scientific Scimed, Inc. |
Embolization
|
US8173176B2
(en)
|
2004-03-30 |
2012-05-08 |
Boston Scientific Scimed, Inc. |
Embolization
|
US20050238870A1
(en)
*
|
2004-04-22 |
2005-10-27 |
Marcia Buiser |
Embolization
|
US7311861B2
(en)
*
|
2004-06-01 |
2007-12-25 |
Boston Scientific Scimed, Inc. |
Embolization
|
US20090155331A1
(en)
*
|
2005-11-16 |
2009-06-18 |
Elan Pharma International Limited |
Injectable nanoparticulate olanzapine formulations
|
WO2006055603A2
(en)
*
|
2004-11-16 |
2006-05-26 |
Elan Pharma International Ltd. |
Injectable nanoparticulate olanzapine formulations
|
US8425550B2
(en)
*
|
2004-12-01 |
2013-04-23 |
Boston Scientific Scimed, Inc. |
Embolic coils
|
US7858183B2
(en)
*
|
2005-03-02 |
2010-12-28 |
Boston Scientific Scimed, Inc. |
Particles
|
US7727555B2
(en)
*
|
2005-03-02 |
2010-06-01 |
Boston Scientific Scimed, Inc. |
Particles
|
WO2006096462A1
(en)
*
|
2005-03-03 |
2006-09-14 |
Elan Pharma International Limited |
Nanoparticulate compositions of heterocyclic amide derivatives
|
JP4954870B2
(ja)
*
|
2005-04-28 |
2012-06-20 |
株式会社明治 |
即溶性顆粒及びその製造方法
|
US7963287B2
(en)
|
2005-04-28 |
2011-06-21 |
Boston Scientific Scimed, Inc. |
Tissue-treatment methods
|
US20070004973A1
(en)
*
|
2005-06-15 |
2007-01-04 |
Tan Sharon M L |
Tissue treatment methods
|
US9463426B2
(en)
*
|
2005-06-24 |
2016-10-11 |
Boston Scientific Scimed, Inc. |
Methods and systems for coating particles
|
US8007509B2
(en)
*
|
2005-10-12 |
2011-08-30 |
Boston Scientific Scimed, Inc. |
Coil assemblies, components and methods
|
US20070083219A1
(en)
*
|
2005-10-12 |
2007-04-12 |
Buiser Marcia S |
Embolic coil introducer sheath locking mechanisms
|
US8101197B2
(en)
|
2005-12-19 |
2012-01-24 |
Stryker Corporation |
Forming coils
|
US8152839B2
(en)
*
|
2005-12-19 |
2012-04-10 |
Boston Scientific Scimed, Inc. |
Embolic coils
|
US20070142859A1
(en)
*
|
2005-12-19 |
2007-06-21 |
Boston Scientific Scimed, Inc. |
Embolic coils
|
US7947368B2
(en)
*
|
2005-12-21 |
2011-05-24 |
Boston Scientific Scimed, Inc. |
Block copolymer particles
|
US7501179B2
(en)
*
|
2005-12-21 |
2009-03-10 |
Boston Scientific Scimed, Inc. |
Block copolymer particles
|
EP1870649A1
(de)
*
|
2006-06-20 |
2007-12-26 |
Octapharma AG |
Gefriertocknung zum Erzielen einer bestimmte Restfeuchte durch beschränkte Desorptionsenergiepegeln.
|
US20070299461A1
(en)
*
|
2006-06-21 |
2007-12-27 |
Boston Scientific Scimed, Inc. |
Embolic coils and related components, systems, and methods
|
US20080031947A1
(en)
*
|
2006-07-24 |
2008-02-07 |
Cima Labs Inc. |
Orally dissolvable/disintegrable lyophilized dosage forms containing protected
|
EP1891938A1
(de)
*
|
2006-07-24 |
2008-02-27 |
Cephalon France |
Mündlich auflösbare hohe Dosis von einer gefriergetrockneten Dosierungsform.
|
EP1905429A1
(de)
*
|
2006-09-18 |
2008-04-02 |
Cephalon France |
Im Munde lösliche/zerfallende lyophilisierte Dosierungsformen enthaltend geschützten Teilchen
|
CL2007002689A1
(es)
|
2006-09-18 |
2008-04-18 |
Vitae Pharmaceuticals Inc |
Compuestos derivados de piperidin-1-carboxamida, inhibidores de la renina; compuestos intermediarios; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como hipertension, insuficiencia cardiaca, fibrosis cardiaca, entre otras.
|
TWI343262B
(en)
*
|
2006-09-26 |
2011-06-11 |
Schering Corp |
Rapidly disintegrating lyophilized oral formulations of a thrombin receptor antagonist
|
US8414927B2
(en)
|
2006-11-03 |
2013-04-09 |
Boston Scientific Scimed, Inc. |
Cross-linked polymer particles
|
US20080145658A1
(en)
*
|
2006-12-15 |
2008-06-19 |
Boston Scientific Scimed, Inc. |
Freeze Thaw Methods For Making Polymer Particles
|
EP1980245A1
(de)
*
|
2007-04-11 |
2008-10-15 |
Cephalon France |
Gefriergetrocknete pharmazeutische Zweischicht-Zusammensetzungen sowie Methoden zur Herstellung und Verwendung derselben
|
US8642062B2
(en)
|
2007-10-31 |
2014-02-04 |
Abbott Cardiovascular Systems Inc. |
Implantable device having a slow dissolving polymer
|
US9399012B2
(en)
*
|
2007-11-13 |
2016-07-26 |
Mallinckrodt Ip |
Reduced dose intravenous acetaminophen
|
WO2009067396A1
(en)
*
|
2007-11-19 |
2009-05-28 |
Avon Products, Inc. |
Composition and method for dry application of mascara
|
US20090238867A1
(en)
*
|
2007-12-13 |
2009-09-24 |
Scott Jenkins |
Nanoparticulate Anidulafungin Compositions and Methods for Making the Same
|
US20090311335A1
(en)
*
|
2008-06-12 |
2009-12-17 |
Scott Jenkins |
Combination of a triptan and an nsaid
|
EP2201939A1
(de)
*
|
2008-12-25 |
2010-06-30 |
Zentiva Kimyasal Ürünler Sanayi ve Ticaret A.S. |
Verfahrung zur Herstellung von beschichtetem Spiramycin und neue Formulierungen damit
|
US7828996B1
(en)
*
|
2009-03-27 |
2010-11-09 |
Abbott Cardiovascular Systems Inc. |
Method for the manufacture of stable, nano-sized particles
|
TWI471127B
(zh)
|
2009-04-29 |
2015-02-01 |
Intervet Int Bv |
供人類使用之口服崩解錠劑的製備方法、所製得之口服崩解錠劑、以及含有該口服崩解錠劑的包裝物
|
FR2945950A1
(fr)
|
2009-05-27 |
2010-12-03 |
Elan Pharma Int Ltd |
Compositions de nanoparticules anticancereuses et procedes pour les preparer
|
US20100323067A1
(en)
*
|
2009-06-19 |
2010-12-23 |
Hershey Foods Corporation |
Temperature resistant chocolate composition and method
|
AR077692A1
(es)
|
2009-08-06 |
2011-09-14 |
Vitae Pharmaceuticals Inc |
Sales de 2-((r)-(3-clorofenil) ((r)-1-((s) -2-(metilamino)-3-((r)-tetrahidro-2h-piran-3-il) propilcarbamoil) piperidin -3-il) metoxi) etilcarbamato de metilo
|
CA2785607A1
(en)
|
2010-01-04 |
2011-07-07 |
Intervet International B.V. |
Administration route for a composition to protect an animal against rhodococcus equi
|
RS56023B1
(sr)
|
2011-07-22 |
2017-09-29 |
Chemocentryx Inc |
Kristalni oblik natrijumove soli 4-terc-butil-n-[4-hlor-2-(1-okso-piridin-4-karbonil)-fenil]-benzensulfonamida
|
CN103813793A
(zh)
|
2011-07-22 |
2014-05-21 |
葛兰素史克知识产权开发有限公司 |
4-叔丁基-n-[4-氯-2-(1-氧基-吡啶-4-羰基)-苯基]-苯磺酰胺钠盐的多晶型
|
JP6199291B2
(ja)
|
2011-09-01 |
2017-09-20 |
グラクソ グループ リミテッドGlaxo Group Limited |
新規な結晶形態
|
US9545376B2
(en)
|
2013-01-23 |
2017-01-17 |
Arx, Llc |
Production of unit dose constructs
|
US9884846B2
(en)
|
2014-06-25 |
2018-02-06 |
Glaxosmithkline Intellectual Property Development Limited |
Crystalline salts of (S)-6-((1 acetylpiperidin-4-yl)amino)-N-(3-(3,4-dihydroisoquinolin-2(1H)-yl)-2-hydroxypropyl)pyrimidine-4-carboxamide
|
RU2017111590A
(ru)
|
2014-09-08 |
2018-10-10 |
Глэксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед |
Кристаллические формы 2-(4-(4-этокси-6-оксо-1,6-дигидропиридин-3-ил)-2-фторфенил)-n-(5-(1,1,1-трифтор-2- метилпропан-2-ил)изоксазол-3-ил)ацетамида
|
BR112020004983A2
(pt)
*
|
2017-09-15 |
2020-09-15 |
Oxular Limited |
dispositivo de canulação para administrar um agente ativo que contém composição a um olho, método para o tratamento de uma doença ou afecção pela entrega de um material líquido ou semissólido para a região afetada, método para o tratamento de uma doença ou afecção ocular por meio da injeção de um material sólido ou semissólido para o espaço supracoroide ou espaço supraciliar e método para a injeção de um materiço supracoroide ou espaço supraciliar pelo uso do dispositivoal no espa
|
EP4135659A1
(de)
|
2020-04-16 |
2023-02-22 |
Tavanta Therapeutics Hungary Incorporated |
Verfahren und zusammensetzungen zur behandlung von prostatakrebs
|